PRA-216

Prana Therapies Inc · Phase 1 active Small molecule

At a glance

Generic name	PRA-216
Sponsor	Prana Therapies Inc
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PRA-216 CI brief — competitive landscape report
PRA-216 updates RSS · CI watch RSS
Prana Therapies Inc portfolio CI